by Vora Corporate Finance | Nov 4, 2023 | Articles, Capital Market Updates
The Indian GDP growth came in at a solid 7.8% YoY in Q1 FY 2024 with both consumption and investment activity growing at robust rate. World leaders will be in India for the G20 meet. Nifty 50 and Sensex correctedmarginally August 2023, however midcap index was able to...
by Vora Corporate Finance | Oct 28, 2023 | Insights, Private Equity & IPO
Transaction: India Resurgence Fund (IndiaRF), promoted by Piramal Enterprises Limited and Bain Capital, Invested Rs. 525 Crores in Ivy Health and Life Sciences Private Limited (Ivy). The hospital is estimated to be valued at Rs 1100 Crores. About India Resurgence Fund...
by Vora Corporate Finance | Oct 28, 2023 | Insights, Merger & Acquisitions
Transaction: Glenmark Pharmaceuticals Limited (GPL) has entered into a share purchase agreement with Nirma Limited to divest a 75% stake in Glenmark Lifesciences (GLS) at an EV of Rs 7500 Crores. Current Promoter group to be public shareholders. About Glenmark...
by Vora Corporate Finance | Oct 28, 2023 | Insights
Secondary Market Update: Indian indices corrected marginally by Nifty 50 and Sensex gaining 2% at 19,638.30 and 1.04% at 65,508.32 respectively. In September, FPI sold total equities worth Rs 14,768 Crores. During September, despite of the global concerns and subdued...
by Vora Corporate Finance | Oct 28, 2023 | Insights
India’s inclusion in JP Morgan’s Emerging market bond index JP Morgan Chase & Co. in September said that it would include Indian Government Bond’s in its Government Bond Index- Emerging Markets Global Index Suite from June 2024. The inclusion of Indian Bonds in...
